 Insider Purchases on May 6: Who Is Betting on Their Own Companies I analyzed the latest OpenInsider data on the largest insider purchases. Here’s what really caught my attention. TOP 3 Deals: - **Saverone 2014 (SVRE)** — $4.00/share. Visionwave Holdings fund bought $2.1 billion, increasing its stake by 14%. This isn’t just a purchase; it’s a doubling of the position. A price of $4 at such volumes is a clear bet on a turnaround. - **Hemab Therapeutics (COAG)** — $18.39/share. Ra Capital Management entered with $52 million, increasing its stake by 82%. A large fund is aggressively building a position in biopharma. - **Sportradar Group (SRAD)** — $13.39/share. CEO Carsten Koerl bought $4.55 million of his own money. When a CEO invests over $4.5 million of personal funds, it speaks louder than any reports. What Else Is Worth Noting: - **Berkshire Hathaway (BRK.B)** — a small but telling purchase: +422% to the director’s stake. - **Patrick Industries (PATK)** — consensus: 5 different insiders bought a total of $2.4 million. - **Purple Innovation (PRPL)** — CFO opened a new position at $0.49 (60,000 shares). My Conclusion: The market is giving mixed signals. Big money is flowing into SVRE and COAG — bets on recovery. Patrick Industries shows unanimity within the company. And Berkshire is a reminder that even small purchases by a legendary company are a signal. ⚠️ Not investment advice. Insider transactions are just one of many indicators.